source
- Cue Biopharma names Shao‑Lee Lin CEO and licenses new allergy asset from Taiwan and ChinaCue Biopharma announced a reboot, bringing in biotech veteran Shao‑Lee Lin as its new chief executive. Lin, founder of Acelyrin, will lead the Boston‑based company as it expands its pipeline. The…
- Premium subscribers invited to exclusive post-hoc Q1 earnings recap live eventA live, post‑hoc session will be held for premium subscribers that reviews first‑quarter earnings across the pharmaceutical sector, with a particular focus on the deal activity reported in the call…